Rapamycin prevents retinal neovascularization by downregulation of cyclin D1 in a mouse model of oxygen-induced retinopathy

Abstract Background Rapamycin (RAPA) is a potent angiogenic inhibitor and the aim of this study is to identify the inhibitory effect of RAPA on retinal neovascularization (RNV) in experimental oxygen-induced retinopathy (OIR). Methods Forty-two 7-day-old C57BL/6 J mice were randomly divided into nor...

Full description

Bibliographic Details
Main Authors: Feng Jiang, Ying Wang, Shufang Du, Heng Jin, Jindong Han
Format: Article
Language:English
Published: BMC 2020-02-01
Series:BMC Ophthalmology
Subjects:
Online Access:https://doi.org/10.1186/s12886-020-1325-5
_version_ 1818676748312641536
author Feng Jiang
Ying Wang
Shufang Du
Heng Jin
Jindong Han
author_facet Feng Jiang
Ying Wang
Shufang Du
Heng Jin
Jindong Han
author_sort Feng Jiang
collection DOAJ
description Abstract Background Rapamycin (RAPA) is a potent angiogenic inhibitor and the aim of this study is to identify the inhibitory effect of RAPA on retinal neovascularization (RNV) in experimental oxygen-induced retinopathy (OIR). Methods Forty-two 7-day-old C57BL/6 J mice were randomly divided into normoxia control group (14 mice), OIR group (14 mice), and rapamycin (RAPA) group. OIR model was induced in OIR and RAPA group. Vehicle and RAPA (2 mg/kg/d) was injected intraperitoneally daily from postnatal day 12 (P12) in OIR and RAPA groups, respectively. RNV was evaluated using fluorescence angiography and histopathology on P17. Non-perfused areas of retina were analyzed by Image-Pro plus 6.0 software. Retinal expression of cyclin D1 was detected both at mRNA and protein levels. Results RAPA treatment significantly decreased RNV, non-perfused areas and number of endothelial cell nuclei breaking through the internal limiting membrane (ILM) in OIR mice. Moreover, RAPA decreased activation of cyclin D1 in retina caused by OIR. Conclusion RAPA can inhibit RNV by downregulating the expression of cyclin D1, which indicates its therapeutic potential in treating RNV-related diseases.
first_indexed 2024-12-17T08:48:24Z
format Article
id doaj.art-2851a9d4d3124733ac74466a00d35486
institution Directory Open Access Journal
issn 1471-2415
language English
last_indexed 2024-12-17T08:48:24Z
publishDate 2020-02-01
publisher BMC
record_format Article
series BMC Ophthalmology
spelling doaj.art-2851a9d4d3124733ac74466a00d354862022-12-21T21:56:09ZengBMCBMC Ophthalmology1471-24152020-02-012011510.1186/s12886-020-1325-5Rapamycin prevents retinal neovascularization by downregulation of cyclin D1 in a mouse model of oxygen-induced retinopathyFeng Jiang0Ying Wang1Shufang Du2Heng Jin3Jindong Han4Department of Ophthalmology, Tianjin Medical University General HospitalDepartment of Ophthalmology, Shenyang Aier Eye HospitalDepartment of Ophthalmology, Shanxi Eye HospitalDepartment of Emergency Medicine, Tianjin Medical University General HospitalDepartment of Vitreous and Retina, Tianjin Medical University Eye HospitalAbstract Background Rapamycin (RAPA) is a potent angiogenic inhibitor and the aim of this study is to identify the inhibitory effect of RAPA on retinal neovascularization (RNV) in experimental oxygen-induced retinopathy (OIR). Methods Forty-two 7-day-old C57BL/6 J mice were randomly divided into normoxia control group (14 mice), OIR group (14 mice), and rapamycin (RAPA) group. OIR model was induced in OIR and RAPA group. Vehicle and RAPA (2 mg/kg/d) was injected intraperitoneally daily from postnatal day 12 (P12) in OIR and RAPA groups, respectively. RNV was evaluated using fluorescence angiography and histopathology on P17. Non-perfused areas of retina were analyzed by Image-Pro plus 6.0 software. Retinal expression of cyclin D1 was detected both at mRNA and protein levels. Results RAPA treatment significantly decreased RNV, non-perfused areas and number of endothelial cell nuclei breaking through the internal limiting membrane (ILM) in OIR mice. Moreover, RAPA decreased activation of cyclin D1 in retina caused by OIR. Conclusion RAPA can inhibit RNV by downregulating the expression of cyclin D1, which indicates its therapeutic potential in treating RNV-related diseases.https://doi.org/10.1186/s12886-020-1325-5Retinal neovascularizationPreventionRapamycinCell cycleAnimal experiment
spellingShingle Feng Jiang
Ying Wang
Shufang Du
Heng Jin
Jindong Han
Rapamycin prevents retinal neovascularization by downregulation of cyclin D1 in a mouse model of oxygen-induced retinopathy
BMC Ophthalmology
Retinal neovascularization
Prevention
Rapamycin
Cell cycle
Animal experiment
title Rapamycin prevents retinal neovascularization by downregulation of cyclin D1 in a mouse model of oxygen-induced retinopathy
title_full Rapamycin prevents retinal neovascularization by downregulation of cyclin D1 in a mouse model of oxygen-induced retinopathy
title_fullStr Rapamycin prevents retinal neovascularization by downregulation of cyclin D1 in a mouse model of oxygen-induced retinopathy
title_full_unstemmed Rapamycin prevents retinal neovascularization by downregulation of cyclin D1 in a mouse model of oxygen-induced retinopathy
title_short Rapamycin prevents retinal neovascularization by downregulation of cyclin D1 in a mouse model of oxygen-induced retinopathy
title_sort rapamycin prevents retinal neovascularization by downregulation of cyclin d1 in a mouse model of oxygen induced retinopathy
topic Retinal neovascularization
Prevention
Rapamycin
Cell cycle
Animal experiment
url https://doi.org/10.1186/s12886-020-1325-5
work_keys_str_mv AT fengjiang rapamycinpreventsretinalneovascularizationbydownregulationofcyclind1inamousemodelofoxygeninducedretinopathy
AT yingwang rapamycinpreventsretinalneovascularizationbydownregulationofcyclind1inamousemodelofoxygeninducedretinopathy
AT shufangdu rapamycinpreventsretinalneovascularizationbydownregulationofcyclind1inamousemodelofoxygeninducedretinopathy
AT hengjin rapamycinpreventsretinalneovascularizationbydownregulationofcyclind1inamousemodelofoxygeninducedretinopathy
AT jindonghan rapamycinpreventsretinalneovascularizationbydownregulationofcyclind1inamousemodelofoxygeninducedretinopathy